BioSpecifics
BioSpecifics is a New York-based biopharmaceutical company that develops injectable collagenase for the treatment of Dupuytren's contracture and Peyronie's disease.
Business Model:
Revenue: $34.8M
Employees: 2-10
Rankings
Industries / Tags:
Detailed BioSpecifics Information
BioSpecifics was acquired by
Endo Pharmaceuticals Inc.
The acquisition happend on 2020-10-19.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 35 Wilbur Street
City: Lynbrook
State: NY
Zip: 11563
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
BioSpecifics is a New York-based biopharmaceutical company that develops injectable collagenase for the treatment of Dupuytren's contracture and Peyronie's disease.
Contact Phone:
+15165937000
Contact Email:
BioSpecifics went public on 1/10/2003 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
1/10/2003
Ticker Symbol:
BSTC
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
